FDA Approved Products

4,498 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
TEPANIL
diethylpropion hydrochloride
LOE Approaching
ORAL · TABLET
the management of exogenous obesityhigher
1959
NDA
30/100
TEPANIL TEN-TAB
diethylpropion hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
the management of exogenous obesityhigher
1977
NDA
30/100
TERAZOL 3
terconazole
LOE Approaching
J&
Johnson & Johnson
VAGINAL · SUPPOSITORY
1988
SMNDA
30/100
TERAZOL 3
terconazole
LOE Approaching
J&
Johnson & Johnson
VAGINAL · CREAM
1991
SMNDA
30/100
TERAZOL 7
terconazole
LOE Approaching
J&
Johnson & Johnson
VAGINAL · CREAM
1987
SMNDA
30/100
TERCONAZOLE
terconazole
LOE Approaching
SandozSandoz
VAGINAL · CREAM
2004
SMNDA
30/100
TERRAMYCIN
oxytetracycline hydrochloride
LOE Approaching
PfizerPfizer
ORAL · CAPSULE
1964
NDA
30/100
TERRAMYCIN W/ POLYMYXIN B SULFATE
oxytetracycline hydrochloride; polymyxin b sulfate
LOE Approaching
R-Pharm USR-Pharm US
OPHTHALMIC · OINTMENT
1965
NDA
30/100
TESLAC
testolactone
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · TABLET
1970
NDA
30/100
TESLAC
testolactone
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
INJECTION · INJECTABLE
1969
NDA
30/100
TESLASCAN
mangafodipir trisodium
LOE Approaching
INJECTION · INJECTABLE
1997
NDA
30/100
TESSALON
benzonatate
LOE Approaching
PfizerPfizer
ORAL · CAPSULE
1958
NDA
30/100
TESTIM
testosterone
LOE Approaching
TRANSDERMAL · GEL
2002
NDA
30/100
TESTODERM
testosterone
LOE Approaching
TRANSDERMAL · FILM, EXTENDED RELEASE
1993
NDA
30/100
TESTODERM TTS
testosterone
LOE Approaching
TRANSDERMAL · FILM, EXTENDED RELEASE
1997
NDA
30/100
TESULOID
technetium tc-99m sulfur colloid kit
LOE Approaching
BraccoBracco
INJECTION, ORAL · SOLUTION
1974
NDA
30/100
TETREX
tetracycline phosphate complex
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · CAPSULE
1957
NDA
30/100
TEVETEN
eprosartan mesylate
LOE Approaching
AbbVieAbbVie
ORAL · TABLET
hypertension
1997
NDA
30/100
TEVETEN HCT
eprosartan mesylate; hydrochlorothiazide
LOE Approaching
AbbVieAbbVie
ORAL · TABLET
2001
NDA
30/100
THALITONE
chlorthalidone
LOE Approaching
R-Pharm USR-Pharm US
ORAL · TABLET
1988
NDA
30/100
THALLOUS CHLORIDE TL 201
thallous chloride tl-201
LOE Approaching
GH
GE HealthCare
INJECTION · INJECTABLE
1982
NDA
30/100
THALLOUS CHLORIDE TL 201
thallous chloride tl-201
LOE Approaching
Lantheus Medical ImagingLantheus Medical Imaging
INTRAVENOUS · INJECTABLE
1977
NDA
30/100
THALLOUS CHLORIDE TL 201
thallous chloride tl-201
LOE Approaching
BraccoBracco
INJECTION · INJECTABLE
1982
NDA
30/100
THALLOUS CHLORIDE TL 201
thallous chloride, tl 201
LOE Approaching
Curium PharmaCurium Pharma
INJECTION · INJECTABLE
1979
NDA
30/100
← PreviousPage 155 of 188Next →